These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 24383421)

  • 1. Cellular uptake and intracellular trafficking of oligonucleotides: implications for oligonucleotide pharmacology.
    Juliano RL; Ming X; Carver K; Laing B
    Nucleic Acid Ther; 2014 Apr; 24(2):101-13. PubMed ID: 24383421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracellular Trafficking and Endosomal Release of Oligonucleotides: What We Know and What We Don't.
    Juliano RL
    Nucleic Acid Ther; 2018 Jun; 28(3):166-177. PubMed ID: 29708838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receptors, endocytosis, and trafficking: the biological basis of targeted delivery of antisense and siRNA oligonucleotides.
    Juliano RL; Carver K; Cao C; Ming X
    J Drug Target; 2013 Jan; 21(1):27-43. PubMed ID: 23163768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms and strategies for effective delivery of antisense and siRNA oligonucleotides.
    Juliano R; Alam MR; Dixit V; Kang H
    Nucleic Acids Res; 2008 Jul; 36(12):4158-71. PubMed ID: 18558618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current Challenges in Delivery and Cytosolic Translocation of Therapeutic RNAs.
    Johannes L; Lucchino M
    Nucleic Acid Ther; 2018 Jun; 28(3):178-193. PubMed ID: 29883296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular uptake and intracellular trafficking of antisense and siRNA oligonucleotides.
    Juliano RL; Ming X; Nakagawa O
    Bioconjug Chem; 2012 Feb; 23(2):147-57. PubMed ID: 21992697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular delivery of siRNA and antisense oligonucleotides via receptor-mediated endocytosis.
    Ming X
    Expert Opin Drug Deliv; 2011 Apr; 8(4):435-49. PubMed ID: 21381985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular uptake and intracellular trafficking of oligonucleotides.
    Juliano RL; Carver K
    Adv Drug Deliv Rev; 2015 Jun; 87():35-45. PubMed ID: 25881722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative Measurement of Cytosolic and Nuclear Penetration of Oligonucleotide Therapeutics.
    Deprey K; Batistatou N; Debets MF; Godfrey J; VanderWall KB; Miles RR; Shehaj L; Guo J; Andreucci A; Kandasamy P; Lu G; Shimizu M; Vargeese C; Kritzer JA
    ACS Chem Biol; 2022 Feb; 17(2):348-360. PubMed ID: 35034446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptor-Mediated Uptake of Phosphorothioate Antisense Oligonucleotides in Different Cell Types of the Liver.
    Miller CM; Tanowitz M; Donner AJ; Prakash TP; Swayze EE; Harris EN; Seth PP
    Nucleic Acid Ther; 2018 Jun; 28(3):119-127. PubMed ID: 29425080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted intracellular delivery of antisense oligonucleotides via conjugation with small-molecule ligands.
    Nakagawa O; Ming X; Huang L; Juliano RL
    J Am Chem Soc; 2010 Jul; 132(26):8848-9. PubMed ID: 20550198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocytosis Controls siRNA Efficiency: Implications for siRNA Delivery Vehicle Design and Cell-Specific Targeting.
    Vocelle D; Chan C; Walton SP
    Nucleic Acid Ther; 2020 Feb; 30(1):22-32. PubMed ID: 31718426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Typical and atypical trafficking pathways of Ad5 penton base recombinant protein: implications for gene transfer.
    Rentsendorj A; Xie J; MacVeigh M; Agadjanian H; Bass S; Kim DH; Rossi J; Hamm-Alvarez SF; Medina-Kauwe LK
    Gene Ther; 2006 May; 13(10):821-36. PubMed ID: 16482205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient delivery of intact phosphodiester oligonucleotides by poly-beta-amino esters.
    Remaut K; Symens N; Lucas B; Demeester J; De Smedt SC
    J Control Release; 2010 May; 144(1):65-74. PubMed ID: 20114066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted delivery of a splice-switching oligonucleotide by cationic polyplexes of RGD-oligonucleotide conjugate.
    Ming X; Feng L
    Mol Pharm; 2012 May; 9(5):1502-10. PubMed ID: 22497548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular distribution and mechanism of delivery of oligonucleotides mediated by cationic lipids.
    Zelphati O; Szoka FC
    Pharm Res; 1996 Sep; 13(9):1367-72. PubMed ID: 8893276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The chemistry and biology of oligonucleotide conjugates.
    Juliano RL; Ming X; Nakagawa O
    Acc Chem Res; 2012 Jul; 45(7):1067-76. PubMed ID: 22353142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The delivery of therapeutic oligonucleotides.
    Juliano RL
    Nucleic Acids Res; 2016 Aug; 44(14):6518-48. PubMed ID: 27084936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unconventional internalization mechanisms underlying functional delivery of antisense oligonucleotides via cationic lipoplexes and polyplexes.
    Ming X; Sato K; Juliano RL
    J Control Release; 2011 Jul; 153(1):83-92. PubMed ID: 21571016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The small molecule Retro-1 enhances the pharmacological actions of antisense and splice switching oligonucleotides.
    Ming X; Carver K; Fisher M; Noel R; Cintrat JC; Gillet D; Barbier J; Cao C; Bauman J; Juliano RL
    Nucleic Acids Res; 2013 Apr; 41(6):3673-87. PubMed ID: 23396438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.